Lysosomal exocytosis is impaired in mucolipidosis type IV. (Q50645963)

17 March 2018

title

Lysosomal exocytosis is impaired in mucolipidosis type IV. (English)

1 reference

17 March 2018

1 reference

Janice M LaPlante

1

1 reference

17 March 2018

Mei Sun

2

1 reference

17 March 2018

John Falardeau

3

1 reference

17 March 2018

Daisy Dai

4

1 reference

17 March 2018

Edward M Brown

5

1 reference

17 March 2018

Susan A Slaugenhaupt

6

1 reference

17 March 2018

Peter M Vassilev

7

1 reference

17 March 2018

publication date

17 August 2006

1 reference

17 March 2018

Molecular Genetics and Metabolism

published in

1 reference

17 March 2018

volume

89

1 reference

17 March 2018

issue

4

1 reference

17 March 2018

page(s)

339-348

1 reference

17 March 2018

Mucolipidosis type IV is caused by mutations in a gene encoding a novel transient receptor potential channel

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.05.016

Identification of the gene causing mucolipidosis type IV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.05.016

Cloning of the gene encoding a novel integral membrane protein, mucolipidin-and identification of the two major founder mutations causing mucolipidosis type IV

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.05.016

Congenital corneal clouding with abnormal systemic storage bodies: A new variant of mucolipidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.05.016

The molecular basis of mucolipidosis type IV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.05.016

Mucolipidosis IV consists of one complementation group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.05.016

Mucolipidosis type IV: abnormal transport of lipids to lysosomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.05.016

Abnormal transport along the lysosomal pathway in mucolipidosis, type IV disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.05.016

TRP-ML1 regulates lysosomal pH and acidic lysosomal lipid hydrolytic activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.05.016

trp, a novel mammalian gene family essential for agonist-activated capacitative Ca2+ entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.05.016

Ion channels and synaptic organization: analysis of the Drosophila genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.05.016

From worm to man: three subfamilies of TRP channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.05.016

Autosomal dominant polycystic kidney disease: clues to pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.05.016

Polycystin-L is a calcium-regulated cation channel permeable to calcium ions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.05.016

Polycystin-2 is a novel cation channel implicated in defective intracellular Ca(2+) homeostasis in polycystic kidney disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.05.016

Identification and characterization of the single channel function of human mucolipin-1 implicated in mucolipidosis type IV, a disorder affecting the lysosomal pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.05.016

Functional links between mucolipin-1 and Ca2+-dependent membrane trafficking in mucolipidosis IV

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.05.016

Molecular pathophysiology of mucolipidosis type IV: pH dysregulation of the mucolipin-1 cation channel.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.05.016

Cation channel activity of mucolipin-1: the effect of calcium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.05.016

TRP-ML1 is a lysosomal monovalent cation channel that undergoes proteolytic cleavage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.05.016

Exocytotic “constipation” is a mechanism of tubulin/lysosomal interaction in colchicine myopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.05.016

Lysosomes behave as Ca2+-regulated exocytic vesicles in fibroblasts and epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.05.016

Plasma membrane repair is mediated by Ca(2+)-regulated exocytosis of lysosomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.05.016

Overexpression of wild-type and mutant mucolipin proteins in mammalian cells: effects on the late endocytic compartment organization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.05.016

Caenorhabditis elegans functional orthologue of human protein h-mucolipin-1 is required for lysosome biogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.05.016

Purification and characterization of an N-acetyl-beta-D-glucosaminidase from cortical granules of Xenopus laevis eggs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.05.016

Noninvasive diagnosis and ophthalmic features of mucolipidosis type IV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.05.016

Constitutive achlorhydria in mucolipidosis type IV

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.05.016

Muscle involvement in mucolipidosis IV

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.05.016

Novel treatment for neuronopathic lysosomal storage diseases--cell therapy/gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.05.016

Enzyme replacement for lysosomal diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.05.016

Inhibition of substrate synthesis as a strategy for glycolipid lysosomal storage disease therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.05.016

Widespread gene transduction to the central nervous system by adenovirus in utero: implication for prenatal gene therapy to brain involvement of lysosomal storage disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.05.016

Widespread and highly persistent gene transfer to the CNS by retrovirus vector in utero: implication for gene therapy to Krabbe disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.05.016

Identification of SNAREs involved in synaptotagmin VII-regulated lysosomal exocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.05.016

Membrane repair: Ca(2+)-elicited lysosomal exocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.05.016

Synaptotagmin VII regulates Ca(2+)-dependent exocytosis of lysosomes in fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.05.016

There's more to life than neurotransmission: the regulation of exocytosis by synaptotagmin VII.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.05.016

Synaptotagmin II negatively regulates Ca2+-triggered exocytosis of lysosomes in mast cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.05.016

The role of intraorganellar Ca(2+) in late endosome-lysosome heterotypic fusion and in the reformation of lysosomes from hybrid organelles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.05.016

Ca2+/calmodulin signals the completion of docking and triggers a late step of vacuole fusion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.05.016

Membrane fusion. Ready...aim...fire!

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.05.016

CUPpling calcium to lysosomal biogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.05.016

Membrane proximal lysosomes are the major vesicles responsible for calcium-dependent exocytosis in nonsecretory cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.05.016

Doc2 enhances Ca2+-dependent exocytosis from PC12 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.05.016

Interaction of Doc2 with tctex-1, a light chain of cytoplasmic dynein. Implication in dynein-dependent vesicle transport

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.05.016

Dynamic changes in chromaffin cell cytoskeleton as prelude to exocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.05.016

Actin filaments and myosin I alpha cooperate with microtubules for the movement of lysosomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.05.016

10.1016/J.YMGME.2006.05.016

7 January 2021

Identifiers

DOI

1 reference

17 March 2018

PubMed ID

16914343

1 reference

17 March 2018